Market Cap 49.10M
Revenue (ttm) 25.18M
Net Income (ttm) -11.89M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -47.22%
Debt to Equity Ratio -6.10
Volume 38,300
Avg Vol 67,420
Day's Range N/A - N/A
Shares Out 8.00M
Stochastic %K 22%
Beta 0.48
Analysts Strong Sell
Price Target $19.60

Company Profile

electroCore, Inc., a bioelectronic medicine and general wellness company, provides non-invasive vagus nerve stimulation (“nVNS”) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also deve...

Industry: Medical Devices
Sector: Healthcare
Phone: 973 290 0097
Fax: 973 290 9171
Address:
200 Forge Way, Suite 205, Rockaway, United States
1621CAPITAL
1621CAPITAL Mar. 16 at 7:02 PM
0 · Reply
cgcapitalresearch
cgcapitalresearch Mar. 13 at 5:31 PM
$ECOR Earnings Preview — Revenue Momentum Across VA and Wellness Channels: We maintain our Outperform rating and $20 price target on electroCore, Inc. (NASDAQ: ECOR) as the commercial-stage bioelectronic medicine company approaches a key inflection point driven by accelerating revenue momentum, improving operating leverage, and expanding clinical applications for its non-invasive vagus nerve stimulation (nVNS) platform. Read more: https://hubs.ly/Q046MpXP0
0 · Reply
B2iDigital
B2iDigital Mar. 11 at 2:10 PM
As Marketing Partner for the 38th Annual ROTH Capital Partners Conference, B2i Digital is spotlighting presenting company electroCore, Inc. ($ECOR ). electroCore is a bioelectronic technology company whose mission is to improve health and quality of life through innovative non-invasive bioelectronic technologies. The Company’s two leading prescription products to treat chronic pain syndromes through non-invasive neuromodulation technology are gammaCore non-invasive vagus nerve stimulation, or nVNS, and the Quell® Fibromyalgia. Additionally, the Company commercializes its handheld and personal use Trvuaga and TAC-STIM nVNS products utilizing bioelectronic technologies to promote general wellness and human performance. Presenting company website: http://www.electrocore.com/ B2i Digital Featured Conference details: https://b2idigital.com/38th-annual-roth-conference The 38th Annual ROTH Conference is an invitation-only corporate access event connecting executive teams from roughly 500 growth companies with institutional investors and other market participants. The conference is held at The Ritz-Carlton Laguna Niguel in Dana Point, California, March 22 to 24, 2026. It is one of the largest small-cap investor conferences in the United States. Conference features include: • 1-on-1 and small group management-investor meetings • Analyst-selected fireside chats, industry keynotes, and panels • ROTH Consumer Private Company Day & Emerging Brand Showcase • Inaugural Engineering & Construction Day (NEW) • ROTH/CAF Charity Ride, Spin, Yoga, Pickleball & Golf (Sunday) • Networking receptions and live evening entertainment B2i Digital, The Capital Markets Matchmaker℠, will leverage its network of 1.5 million+ investors to help enhance visibility for presenting companies, aligned with our mantra, From Marketing to Meetings℠. Registration is required and subject to approval by ROTH: https://www.meetmax.com/sched/event_127123/conference_home.html Credit to the team at ROTH for hosting this premier event: Byron Roth, Aaron Gurewitz, Isabel Mattson-Pain, Nazan Akdeniz, Otilia Charo, Grace Deller, Amanda McAdams, Jason Wittes, Boobalan Pachaiyappan, Jonathan Aschoff, Harry Fong, James Antonopoulos, Ben Bowen, Kris Salinger, Russ Nudelman, Andrew Kellogg, Matthew Robinson, David Farina. David Shapiro and Joseph Azizo from B2i Digital will also be in attendance and look forward to seeing you there. ROTH is a relationship-driven investment bank focused on serving growth companies and their investors across capital raising, equity research, sales and trading, M&A advisory, and corporate access. For more information, visit www.roth.com. B2i Digital is not a broker-dealer or investment adviser. This is for general information only and is not an offer to buy or sell any security.
1 · Reply
taxplanr
taxplanr Mar. 10 at 2:00 PM
$ECOR to participate in Annual Roth Conference https://investor.electrocore.com/news-releases/news-release-details/electrocore-participate-38th-annual-roth-conference
0 · Reply
taxplanr
taxplanr Mar. 4 at 3:19 PM
$ECOR unless there is some big announcement at the QR next week this rally is a pump for another bear attack
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 27 at 7:14 PM
$ECOR RSI: 78.12, MACD: 0.3252 Vol: 0.78, MA20: 6.17, MA50: 5.95 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 26 at 9:08 PM
$ECOR Current Stock Price: $7.65
0 · Reply
stosun
stosun Feb. 26 at 8:26 PM
$ECOR Interesting - today this is one of the few stocks moving up. Around 2/2025 it was around $18. Anyone know why it's creeping back up?
0 · Reply
taxplanr
taxplanr Feb. 18 at 3:06 PM
$ECOR does anyone think pig pHarma wants this study showing the positive effects Truvaga Plus has on Parkinsons disease getting out to the public? Since not make sure to share on all your social media channels https://pmc.ncbi.nlm.nih.gov/articles/PMC10879328/
0 · Reply
6GodEnergy
6GodEnergy Feb. 17 at 7:02 PM
0 · Reply
Latest News on ECOR
electroCore to Participate at the 38th Annual Roth Conference

Mar 10, 2026, 8:00 AM EDT - 6 days ago

electroCore to Participate at the 38th Annual Roth Conference


electroCore, Inc. (ECOR) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 9:51 PM EST - 4 months ago

electroCore, Inc. (ECOR) Q3 2025 Earnings Call Transcript


electroCore Announces Third Quarter 2025 Financial Results

Nov 5, 2025, 4:05 PM EST - 4 months ago

electroCore Announces Third Quarter 2025 Financial Results


Ecora Resources PLC (ECOR:CA) Q2 2025 Earnings Call Transcript

Sep 9, 2025, 2:21 PM EDT - 6 months ago

Ecora Resources PLC (ECOR:CA) Q2 2025 Earnings Call Transcript


electroCore Appoints Elena Bonfiglioli to Board of Directors

Sep 3, 2025, 8:00 AM EDT - 6 months ago

electroCore Appoints Elena Bonfiglioli to Board of Directors


electroCore, Inc. (ECOR) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 11:18 PM EDT - 7 months ago

electroCore, Inc. (ECOR) Q2 2025 Earnings Call Transcript


electroCore Announces Second Quarter 2025 Financial Results

Aug 6, 2025, 4:05 PM EDT - 7 months ago

electroCore Announces Second Quarter 2025 Financial Results


electroCore to Participate in Upcoming Investor Conferences

Jul 22, 2025, 4:05 PM EDT - 8 months ago

electroCore to Participate in Upcoming Investor Conferences


electroCore, Inc. (ECOR) Q1 2025 Earnings Call Transcript

May 7, 2025, 11:16 PM EDT - 11 months ago

electroCore, Inc. (ECOR) Q1 2025 Earnings Call Transcript


electroCore Announces First Quarter 2025 Financial Results

May 7, 2025, 4:05 PM EDT - 11 months ago

electroCore Announces First Quarter 2025 Financial Results


electroCore's Truvaga™ Now Works with the Apple Health app

May 1, 2025, 8:00 AM EDT - 11 months ago

electroCore's Truvaga™ Now Works with the Apple Health app


electroCore to Participate at the Planet MicroCap Showcase

Apr 16, 2025, 8:00 AM EDT - 11 months ago

electroCore to Participate at the Planet MicroCap Showcase


electroCore Extends VA Contract for Five Years

Mar 31, 2025, 8:00 AM EDT - 1 year ago

electroCore Extends VA Contract for Five Years


electroCore, Inc. (ECOR) Q4 2024 Earnings Call Transcript

Mar 12, 2025, 9:36 PM EDT - 1 year ago

electroCore, Inc. (ECOR) Q4 2024 Earnings Call Transcript


electroCore Announces Full Year 2024 Financial Results

Mar 12, 2025, 4:05 PM EDT - 1 year ago

electroCore Announces Full Year 2024 Financial Results


electroCore to Participate at Upcoming Investor Conferences

Mar 5, 2025, 8:00 AM EST - 1 year ago

electroCore to Participate at Upcoming Investor Conferences


electroCore, Inc. (ECOR) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 9:18 PM EST - 1 year ago

electroCore, Inc. (ECOR) Q3 2024 Earnings Call Transcript


electroCore Announces Third Quarter 2024 Financial Results

Nov 13, 2024, 4:01 PM EST - 1 year ago

electroCore Announces Third Quarter 2024 Financial Results


electroCore to Participate at LD Micro Main Event VXII

Oct 14, 2024, 8:00 AM EDT - 1 year ago

electroCore to Participate at LD Micro Main Event VXII


1621CAPITAL
1621CAPITAL Mar. 16 at 7:02 PM
0 · Reply
cgcapitalresearch
cgcapitalresearch Mar. 13 at 5:31 PM
$ECOR Earnings Preview — Revenue Momentum Across VA and Wellness Channels: We maintain our Outperform rating and $20 price target on electroCore, Inc. (NASDAQ: ECOR) as the commercial-stage bioelectronic medicine company approaches a key inflection point driven by accelerating revenue momentum, improving operating leverage, and expanding clinical applications for its non-invasive vagus nerve stimulation (nVNS) platform. Read more: https://hubs.ly/Q046MpXP0
0 · Reply
B2iDigital
B2iDigital Mar. 11 at 2:10 PM
As Marketing Partner for the 38th Annual ROTH Capital Partners Conference, B2i Digital is spotlighting presenting company electroCore, Inc. ($ECOR ). electroCore is a bioelectronic technology company whose mission is to improve health and quality of life through innovative non-invasive bioelectronic technologies. The Company’s two leading prescription products to treat chronic pain syndromes through non-invasive neuromodulation technology are gammaCore non-invasive vagus nerve stimulation, or nVNS, and the Quell® Fibromyalgia. Additionally, the Company commercializes its handheld and personal use Trvuaga and TAC-STIM nVNS products utilizing bioelectronic technologies to promote general wellness and human performance. Presenting company website: http://www.electrocore.com/ B2i Digital Featured Conference details: https://b2idigital.com/38th-annual-roth-conference The 38th Annual ROTH Conference is an invitation-only corporate access event connecting executive teams from roughly 500 growth companies with institutional investors and other market participants. The conference is held at The Ritz-Carlton Laguna Niguel in Dana Point, California, March 22 to 24, 2026. It is one of the largest small-cap investor conferences in the United States. Conference features include: • 1-on-1 and small group management-investor meetings • Analyst-selected fireside chats, industry keynotes, and panels • ROTH Consumer Private Company Day & Emerging Brand Showcase • Inaugural Engineering & Construction Day (NEW) • ROTH/CAF Charity Ride, Spin, Yoga, Pickleball & Golf (Sunday) • Networking receptions and live evening entertainment B2i Digital, The Capital Markets Matchmaker℠, will leverage its network of 1.5 million+ investors to help enhance visibility for presenting companies, aligned with our mantra, From Marketing to Meetings℠. Registration is required and subject to approval by ROTH: https://www.meetmax.com/sched/event_127123/conference_home.html Credit to the team at ROTH for hosting this premier event: Byron Roth, Aaron Gurewitz, Isabel Mattson-Pain, Nazan Akdeniz, Otilia Charo, Grace Deller, Amanda McAdams, Jason Wittes, Boobalan Pachaiyappan, Jonathan Aschoff, Harry Fong, James Antonopoulos, Ben Bowen, Kris Salinger, Russ Nudelman, Andrew Kellogg, Matthew Robinson, David Farina. David Shapiro and Joseph Azizo from B2i Digital will also be in attendance and look forward to seeing you there. ROTH is a relationship-driven investment bank focused on serving growth companies and their investors across capital raising, equity research, sales and trading, M&A advisory, and corporate access. For more information, visit www.roth.com. B2i Digital is not a broker-dealer or investment adviser. This is for general information only and is not an offer to buy or sell any security.
1 · Reply
taxplanr
taxplanr Mar. 10 at 2:00 PM
$ECOR to participate in Annual Roth Conference https://investor.electrocore.com/news-releases/news-release-details/electrocore-participate-38th-annual-roth-conference
0 · Reply
taxplanr
taxplanr Mar. 4 at 3:19 PM
$ECOR unless there is some big announcement at the QR next week this rally is a pump for another bear attack
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 27 at 7:14 PM
$ECOR RSI: 78.12, MACD: 0.3252 Vol: 0.78, MA20: 6.17, MA50: 5.95 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 26 at 9:08 PM
$ECOR Current Stock Price: $7.65
0 · Reply
stosun
stosun Feb. 26 at 8:26 PM
$ECOR Interesting - today this is one of the few stocks moving up. Around 2/2025 it was around $18. Anyone know why it's creeping back up?
0 · Reply
taxplanr
taxplanr Feb. 18 at 3:06 PM
$ECOR does anyone think pig pHarma wants this study showing the positive effects Truvaga Plus has on Parkinsons disease getting out to the public? Since not make sure to share on all your social media channels https://pmc.ncbi.nlm.nih.gov/articles/PMC10879328/
0 · Reply
6GodEnergy
6GodEnergy Feb. 17 at 7:02 PM
0 · Reply
VolatilitySurface
VolatilitySurface Feb. 17 at 12:24 PM
$ECOR Micro-cap biotech; clinical-stage with partnership dependence.
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 9 at 9:08 PM
$ECOR Current Stock Price: $5.42
0 · Reply
GammaView
GammaView Feb. 9 at 2:17 PM
$ECOR Medical device for electrophysiology; requires surgeon training and adoption.
0 · Reply
taxplanr
taxplanr Feb. 5 at 3:00 PM
$ECOR I got my Truvaga Plus software update on Android this morning
1 · Reply
taxplanr
taxplanr Jan. 29 at 3:15 PM
$ECOR CFO Lev purchases more shares https://investor.electrocore.com/node/11936/html
1 · Reply
taxplanr
taxplanr Jan. 29 at 3:13 PM
$ECOR CEO Goldberger makes sizable purchase https://investor.electrocore.com/node/11931/html
1 · Reply
Mudloaf
Mudloaf Jan. 21 at 4:13 PM
$ECOR what’s going on here
0 · Reply
taxplanr
taxplanr Jan. 21 at 3:28 PM
$ECOR It's not as good as a sale but users know what the outcome will be come November https://investor.electrocore.com/news-releases/news-release-details/acacia-clinics-and-vagus-nerve-society-conduct-study-using
1 · Reply
Stock_Catcher
Stock_Catcher Jan. 21 at 1:01 PM
$ECOR ​​ECOR Acacia Clinics and Vagus Nerve Society Conduct Study Using electroCore’s gammaCore Sapphire for Adjunctive Treatment of Symptoms Associated with Post-Traumatic Stress Disorder (“PTSD”)
0 · Reply
taxplanr
taxplanr Jan. 20 at 2:46 PM
$ECOR provides 2025 full year update https://investor.electrocore.com/news-releases/news-release-details/electrocore-provides-preliminary-full-year-2025-business-update
0 · Reply
DARKP00L
DARKP00L Jan. 20 at 1:13 PM
$ECOR 08:09 on Jan. 20 2026 electroCore Anticipates Reporting FY25 Revenue Of ~$31.8M-$32M; Estimates Q4 Revenue To Be ~$9M-$9.2M #tradeideas
0 · Reply
taxplanr
taxplanr Jan. 20 at 1:12 AM
$ECOR PEMF kills cancer cells ... while malignantRNA causes cancer $BNTX $MRNA $PFE https://www.instagram.com/reel/DRtC-oejEtL/?igsh=MWo2cGlzMjE1bDFxdQ==
0 · Reply